Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by bazooka73on Jun 29, 2020 10:15am

85 Views

Post# 31202541

RE:RE:Response to Pipelines

MirrorWorldMan wrote: As the management teams in the vast majority of failed BioTechs discovered, good Science alone is not enough. It also takes a reliable cash source, competent management to sell the science and a timelines that does not chisel a revenue accomplishment as a p.s. on investors tombstones.

oh, you forgot: The need of a social media expert!

Bullboard Posts

FE Battery Metals begins 2024 winter drill program